These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27678424)

  • 21. Impact of statins on risk of stroke: a meta-analysis.
    Henyan NN; Riche DM; East HE; Gann PN
    Ann Pharmacother; 2007 Dec; 41(12):1937-45. PubMed ID: 17986516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports.
    Fernández AB; Karas RH; Alsheikh-Ali AA; Thompson PD
    Chest; 2008 Oct; 134(4):824-830. PubMed ID: 18689579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
    Rätz Bravo AE; Tchambaz L; Krähenbühl-Melcher A; Hess L; Schlienger RG; Krähenbühl S
    Drug Saf; 2005; 28(3):263-75. PubMed ID: 15733030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
    Liu B; Yi Z; Guan X; Zeng YX; Ma F
    Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of statin-drug interactions in older people: a systematic review.
    Thai M; Reeve E; Hilmer SN; Qi K; Pearson SA; Gnjidic D
    Eur J Clin Pharmacol; 2016 May; 72(5):513-21. PubMed ID: 26790666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-atheroprotective effects of statins: a systematic review.
    Beri A; Sural N; Mahajan SB
    Am J Cardiovasc Drugs; 2009; 9(6):361-70. PubMed ID: 19929034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins use and risk of depression: a systematic review and meta-analysis.
    Parsaik AK; Singh B; Murad MH; Singh K; Mascarenhas SS; Williams MD; Lapid MI; Richardson JW; West CP; Rummans TA
    J Affect Disord; 2014 May; 160():62-7. PubMed ID: 24370264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
    Chuengsamarn S; Rattanamongkoulgul S; Suwanwalaikorn S; Wattanasirichaigoon S; Kaufman L
    Bone; 2010 Apr; 46(4):1011-5. PubMed ID: 20045497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis.
    Petretta M; Costanzo P; Perrone-Filardi P; Chiariello M
    Int J Cardiol; 2010 Jan; 138(1):25-31. PubMed ID: 18793814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study.
    Yeramaneni S; Kleindorfer DO; Sucharew H; Alwell K; Moomaw CJ; Flaherty ML; Woo D; Adeoye O; Ferioli S; de Los Rios La Rosa F; Martini S; Mackey J; Khatri P; Kissela BM; Khoury JC
    Int J Stroke; 2017 Feb; 12(2):152-160. PubMed ID: 27649737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome.
    Prescott WA; Streetman DA; Streetman DS
    Ann Pharmacother; 2004 Dec; 38(12):2105-14. PubMed ID: 15507504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis.
    Gui YJ; Liao CX; Liu Q; Guo Y; Yang T; Chen JY; Wang YT; Hu JH; Xu DY
    Eur J Prev Cardiol; 2017 Jun; 24(9):907-916. PubMed ID: 28436720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis.
    Yu S; Chu Y; Li G; Ren L; Zhang Q; Wu L
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin use and risk of cerebral aneurysm rupture: a hospital-based case-control study in Japan.
    Yoshimura Y; Murakami Y; Saitoh M; Yokoi T; Aoki T; Miura K; Ueshima H; Nozaki K;
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):343-8. PubMed ID: 23697760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of statin therapy in sepsis.
    Chua D; Tsang RS; Kuo IF
    Ann Pharmacother; 2007 Apr; 41(4):647-52. PubMed ID: 17389664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin treatment in multiple sclerosis: a systematic review and meta-analysis.
    Pihl-Jensen G; Tsakiri A; Frederiksen JL
    CNS Drugs; 2015 Apr; 29(4):277-91. PubMed ID: 25795002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of statins in patients with liver disease.
    Kalaitzakis E; Björnsson ES
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):15-24. PubMed ID: 24632765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.